Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Novo Nordisk A/S

    NYSE: NVO · Real-Time Price · USD
    68.50
    0.80 (1.18%)
    At close: Jun 27, 2025, 3:59 PM
    68.60
    0.15%
    After-hours: Jun 27, 2025, 05:58 PM EDT

    Novo Nordisk A/S Statistics

    Share Statistics

    Novo Nordisk A/S has 4.43B shares outstanding. The number of shares has increased by -1.8% in one year.

    Shares Outstanding

    n/a
    		 4.43B

    Shares Change (YoY)

    n/a
    		 -1.8%

    Shares Change (QoQ)

    n/a
    		 -2.35%

    Owned by Institutions (%)

    n/a
    		 7.58%

    Shares Floating

    n/a
    		 4.43B

    Failed to Deliver (FTD) Shares

    n/a
    		 2,842

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 33.67M, so 0.76% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 33.67M

    Short % of Shares Out

    n/a
    		 0.76%

    Short % of Float

    n/a
    		 1%

    Short Ratio (days to cover)

    n/a
    		 3.28

    Valuation Ratios

    The PE ratio is 27.33 and the forward PE ratio is 1.97. Novo Nordisk A/S's PEG ratio is 0.19.

    PE Ratio

    n/a
    		 27.33

    Forward PE

    n/a
    		 1.97

    PS Ratio

    n/a
    		 9.5

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 19.23

    P/FCF Ratio

    n/a
    		 39.62

    PEG Ratio

    n/a
    		 0.19
    Financial Ratio History

    Enterprise Valuation

    Novo Nordisk A/S has an Enterprise Value (EV) of 2,846.7B.

    EV / Sales

    n/a
    		 9.8

    EV / EBITDA

    n/a
    		 20.72

    EV / EBIT

    n/a
    		 23.53

    EV / FCF

    n/a
    		 40.87

    Financial Position

    The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.

    Current Ratio

    n/a
    		 0.74

    Quick Ratio

    n/a
    		 0.55

    Debt / Equity

    n/a
    		 0.72

    Debt / EBITDA

    n/a
    		 0.75

    Debt / FCF

    n/a
    		 1.48

    Interest Coverage

    n/a
    		 78.26

    Financial Efficiency

    Return on Equity is 70.38% and Return on Invested Capital is 38.99%.

    Return on Equity

    n/a
    		 70.38%

    Return on Assets

    n/a
    		 21.68%

    Return on Invested Capital

    n/a
    		 38.99%

    Revenue Per Employee

    n/a
    		 $3,751,685.92

    Profits Per Employee

    n/a
    		 $1,304,653.39

    Employee Count

    n/a
    		 77,406

    Asset Turnover

    n/a
    		 0.62

    Inventory Turnover

    n/a
    		 1.09

    Taxes

    Income Tax

    n/a
    		 26.2B

    Effective Tax Rate

    n/a
    		 20.6%

    Stock Price Statistics

    The stock price has increased by -53.11% in the last 52 weeks. The beta is 0.22, so Novo Nordisk A/S's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.22

    52-Week Price Change

    n/a
    		 -53.11%

    50-Day Moving Average

    n/a
    		 68.63

    200-Day Moving Average

    n/a
    		 90.15

    Relative Strength Index (RSI)

    n/a
    		 40.7

    Average Volume (20 Days)

    n/a
    		 10,387,737

    Income Statement

    In the last 12 months, Novo Nordisk A/S had revenue of 290.4B and earned 100.99B in profits. Earnings per share was 22.67.

    Revenue

    n/a
    		 290.4B

    Gross Profit

    n/a
    		 245.88B

    Operating Income

    n/a
    		 128.34B

    Net Income

    n/a
    		 100.99B

    EBITDA

    n/a
    		 137.38B

    EBIT

    n/a
    		 128.83B

    Earnings Per Share (EPS)

    n/a
    		 22.67
    Full Income Statement

    Balance Sheet

    The company has 15.65B in cash and 102.79B in debt, giving a net cash position of -87.13B.

    Cash & Cash Equivalents

    n/a
    		 15.65B

    Total Debt

    n/a
    		 102.79B

    Net Cash

    n/a
    		 -87.13B

    Retained Earnings

    n/a
    		 144.45B

    Total Assets

    n/a
    		 489.16B

    Working Capital

    n/a
    		 -61.72B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 120.97B and capital expenditures -51.31B, giving a free cash flow of 69.66B.

    Operating Cash Flow

    n/a
    		 120.97B

    Capital Expenditures

    n/a
    		 -51.31B

    Free Cash Flow

    n/a
    		 69.66B

    FCF Per Share

    n/a
    		 15.64
    Full Cash Flow Statement

    Margins

    Gross margin is 84.67%, with operating and profit margins of 44.19% and 34.78%.

    Gross Margin

    n/a
    		 84.67%

    Operating Margin

    n/a
    		 44.19%

    Pretax Margin

    n/a
    		 43.8%

    Profit Margin

    n/a
    		 34.78%

    EBITDA Margin

    n/a
    		 47.31%

    EBIT Margin

    n/a
    		 44.19%

    FCF Margin

    n/a
    		 23.99%

    Dividends & Yields

    NVO pays an annual dividend of $1.61, which amounts to a dividend yield of 2.32%.

    Dividend Per Share

    n/a
    		 $1.61

    Dividend Yield

    n/a
    		 2.32%

    Dividend Growth (YoY)

    n/a
    		 18.21%

    Payout Ratio

    n/a
    		 44.4%

    Earnings Yield

    n/a
    		 3.66%

    FCF Yield

    n/a
    		 2.52%
    Dividend Details

    Analyst Forecast

    The average price target for NVO is $112, which is 65.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $112

    Price Target Difference

    n/a
    		 65.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $458.16

    Lynch Upside

    n/a
    		 576.25%

    Graham Number

    n/a
    		 128.2

    Graham Upside

    n/a
    		 89.23%

    Stock Splits

    The last stock split was on Sep 20, 2023. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Sep 20, 2023

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 2.3

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist